RxDoctor Payments Data

Randall Williams

Physician Assistant · Union City, TNNPI 1013380013

Payments from drug & device makers

$7,885in general payments, 2019–2025

Across 446 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
  • Novartis$1K
  • Boehringer Ingelheim$695
  • Pfizer$608
  • Merck$584
  • plus $3K from 19 others

What the payments were for

  • Food & beverage$7,871100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,885 in reported general payments places this provider in the 95th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$161,309
Medicare patients
912
Services billed
2,924

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban785$637,312
EntrestoSacubitril/Valsartan310$347,370
XareltoRivaroxaban201$196,846
Repatha SureclickEvolocumab259$193,202
OpsumitMacitentan13$166,026
JardianceEmpagliflozin143$153,110
Praluent PenAlirocumab51$35,122
BrilintaTicagrelor55$34,248
FarxigaDapagliflozin Propanediol27$33,789
MultaqDronedarone Hcl25$25,442
CorlanorIvabradine Hcl11$13,242
Atorvastatin Calcium658$10,063
Metoprolol Succinate709$9,538
Ranolazine ErRanolazine72$8,596
Rosuvastatin Calcium484$7,481

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$608$637,312785 claims
NovartisEntresto$1,014$347,370310 claims
Johnson & JohnsonXarelto$563$196,846201 claims
Actelion Pharmaceuticals US, Inc.Opsumit$553$166,02613 claims
Boehringer IngelheimJardiance$695$153,110143 claims
AstraZenecaBrilinta, Farxiga$155$68,03782 claims
Sanofi-aventis U.S. LLCMultaq$18$25,44225 claims
AmgenCorlanor$1,139$13,24211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Union City

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →